Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia

Review of McDonald Criteria 2024 Updates for the Management of Patients with Multiple Sclerosis

Implications of Obstructive Hypertrophic Cardiomyopathy (oHCM) for Heart Failure Specialists

ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

Clinical Strategies for Newer Maintenance Therapies to Reduce Exacerbations in Patients with COPD

DEARA: Blocking 2 Different Renal Receptors to Reduce Proteinuria

PBC Treatment in Practice: Optimizing Second Line & Symptom Therapy

Clinical Trial Data Review for PBC Therapeutics

PBC, Science, Diagnostic Strategies, Optimal Treatment Timing, and Burden of Disease

A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for Generalized Myasthenia Gravis in the Infusion Center

IgA Nephropathy - Epidemiology, Clinical Presentation, Pathophysiology, and Approach to Treatment

VTE and Anticoagulation - Guideline Updates for 2024

Shared Decision-Making & Patient Education to Promote Adherence to DOACs & Continuity of Care in VTE

Review of Clinical Trial and Real-World Data for DOAC and other Anticoagulation Therapeutics for VTE

Part 1: Advances in Patient-Actuated Treatment for PSVT

Part 2: Advances in Patient-Actuated Treatment for PSVT

Applying Poly (ADP-ribose) Polymerase (PARP) Inhibitors to Maintenance Treatment Plans to Improve Outcomes for Patients with Advanced Ovarian Cancer

Hyperkalemia 4: A Multidisciplinary and Interprofessional Approach to Best Treat Hyperkalemia and Associated Comorbidities – Challenging Patient Case Studies